Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

NCT06176690 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

CD30-Positive Diffuse Large B-Cell Lymphoma
Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type
Anaplastic Large Cell Lymphoma, ALK-Positive
Peripheral T-cell Lymphoma
Anaplastic Large Cell Lymphoma, ALK-negative
Non-Hodgkin Lymphoma
Hodgkin Lymphoma

Interventions

BIOLOGICAL: C7R.CD30.CAR-EBVST cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]